Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02690077 · ClinicalTrials.gov registry record · NA

Family-Centered Cesarean Delivery

A NA study of Patient Satisfaction and Earlier Family Bond Initiation, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
149
Enrollment target
2
Study locations

NCT02690077: Completed NA study of Patient Satisfaction and Earlier Family Bond Initiation, sponsored by Wake Forest University Health Sciences.

NCT02690077 is a NA study of Patient Satisfaction and Earlier Family Bond Initiation that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 149 participants, below the 460-participant average among 20 other Patient Satisfaction trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02690077, a NA study of Patient Satisfaction and Earlier Family Bond Initiation, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
149 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine if patient birthing experiences differ between the family-centered and traditional cesarean methods. We hypothesize that the family-centered cesarean method will lead to more unique and personalized cesarean birthing experiences without increasing the risks of adverse neonatal and maternal outcomes from those documented with the traditional cesarean.

Primary Outcome

The primary objective of this study was to compare satisfaction with birthing experiences between women who underwent either a family-centered or traditional cesarean delivery, using a modified Likert scale, ranging from 1 (lowest) to 5 (highest).

Interventions

  • PROCEDURE Family-Centered Cesarean
  • PROCEDURE Traditional Cesarean

Study Locations (2)

Wisconsin

  • Aurora BayCare Medical Center - Green Bay
  • Aurora Sinai Medical Center - Milwaukee

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2016-06-01
Est. Completion 2021-10-29
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT02690077 record still lists

NCT02690077 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 460-participant average among 20 other Patient Satisfaction trials with a reported enrollment target (68% lower).

The record links to 3 conditions, with Patient Satisfaction appearing as the primary indexed condition, and to 2 interventions - of which Family-Centered Cesarean is the first listed.

NCT02690077 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT02690077 about?

NCT02690077 is a clinical study titled "Family-Centered Cesarean Delivery". The purpose of this study is to determine if patient birthing experiences differ between the family-centered and traditional cesarean methods. We hypothesize that the family-centered cesarean method will lead to more unique and personalized cesarean birthing experiences without increasing the risks ...

What is the current status of trial NCT02690077?

This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2016-06-01. Estimated completion is 2021-10-29.

What conditions does trial NCT02690077 study?

This clinical trial studies the following conditions: Patient Satisfaction, Earlier Family Bond Initiation, Maternal and Neonatal Outcomes.

What interventions are being tested in trial NCT02690077?

The interventions under investigation include: Family-Centered Cesarean (PROCEDURE), Traditional Cesarean (PROCEDURE).

Who is sponsoring clinical trial NCT02690077?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02690077 being conducted?

This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Patient Satisfaction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02690077's enrollment target sits among peer trials

149 8th of 20 higher than 13 of 20 other Patient Satisfaction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Patient Satisfaction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04188535 · 149 participants · NA

    Serial MRI Scans During Radiation Therapy

  • NCT05828511 · 149 participants · Phase 1

    A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02690077, the US trial registry maintained by the National Library of Medicine. NCT02690077 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.